What is the debt of Kainos Laboratories this year?
Kainos Laboratories has a debt level of -2,302.43 JPY this year.
In 2024, Kainos Laboratories's total debt was -2,302.43 JPY, a 33.81% change from the -1,720.69 JPY total debt recorded in the previous year.
Kainos Laboratories's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Analyzing Kainos Laboratories's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Investors pay close attention to Kainos Laboratories’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Shifts in Kainos Laboratories’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
Kainos Laboratories has a debt level of -2,302.43 JPY this year.
The debt of Kainos Laboratories has increased by 33.81% compared to the previous year increased.
High debt can pose a risk for investors of Kainos Laboratories, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
Low debt means that Kainos Laboratories has a strong financial position and is able to fulfill its obligations without overburdening its finances.
An increase in debt of Kainos Laboratories can adversely affect the financial condition of the company and result in a higher burden on its finances.
A reduction in debt of Kainos Laboratories can strengthen the company's financial position and improve its ability to meet its financial obligations.
Some factors that can influence the debt of Kainos Laboratories include investments, acquisitions, operating costs, and revenue development.
The debts of Kainos Laboratories are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
To change the debt, Kainos Laboratories can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
Over the past 12 months, Kainos Laboratories paid a dividend of 32 JPY . This corresponds to a dividend yield of about 2.72 %. For the coming 12 months, Kainos Laboratories is expected to pay a dividend of 32 JPY.
The current dividend yield of Kainos Laboratories is 2.72 %.
Kainos Laboratories pays a quarterly dividend. This is distributed in the months of April, April, April, April.
Kainos Laboratories paid dividends every year for the past 16 years.
For the upcoming 12 months, dividends amounting to 32 JPY are expected. This corresponds to a dividend yield of 2.72 %.
Kainos Laboratories is assigned to the 'Health' sector.
To receive the latest dividend of Kainos Laboratories from 6/1/2024 amounting to 32 JPY, you needed to have the stock in your portfolio before the ex-date on 3/28/2024.
The last dividend was paid out on 6/1/2024.
In the year 2023, Kainos Laboratories distributed 25 JPY as dividends.
The dividends of Kainos Laboratories are distributed in JPY.
Our stock analysis for Kainos Laboratories Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kainos Laboratories Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.